At Colorado Blood Cancer Institute, we have established ourselves as clinical trial leaders throughout Colorado, Montana, Wyoming and New Mexico. As these critical trials develop and evolve, we are able to help further cancer treatment outcomes.

Make an appointment

Schedule an appointment with an oncologist

Reach out to us if you have any questions regarding our clinical trials.

For additional information, call (720) 754-4835.

Information on our clinical trials

Our program provides access to the latest cancer clinical trials. These trials have contributed to pivotal research that has led to significant cancer therapies approved by the FDA.

Types of available clinical trials

Through our partnership with the HCA Healthcare Sarah Cannon Cancer Network, we are able to be active contributors to an expansive network advancing therapies for effective cancer treatment. The following clinical trials are available at our facility and across this network:

  • Acute lymphoblastic leukemia (ALL)
    • Hematopoietic cell transplantation
    • Hematologic refractory
  • Acute myeloid leukemia (AML)
    • Hematopoietic cell transplantation
    • Hematologic refractory
  • Amyloid
  • Autoimmune diseases
  • Chronic lymphocytic leukemia (CLL)
    • Hematopoietic cell transplantation
    • Hematologic refractory
  • Chronic myelomonocytic leukemia (CMML)
    • Hematopoietic cell transplantation
    • Hematologic refractory
  • Hematopoietic cell transplantation
  • Hematologic refractory
  • Lymphoma
    • Hematopoietic cell transplantation
    • Hematologic refractory
  • Myelodysplastic syndrome
  • Myeloproliferative neoplasms
  • Multiple myeloma
    • Hematopoietic cell transplantation
    • Hematologic refractory
  • Waldenstrom's macroglobulinemia